EQS-News: Asklepios Kliniken / Key word(s): Quarterly / Interim Statement
Asklepios Kliniken:
25.05.2023 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Asklepios Group: Resilient business performance in Q1 2023
More than 850,000 patients cared for Consolidated revenue amounts to EUR
1,341.8 million Asklepios invests EUR
47.4 million of own funds
Hamburg, 25 May 2023. Asklepios Kliniken GmbH & Co. KGaA has made a resilient start to the first quarter of 2023. As such, Asklepios has established a sound basis for the 2023 financial year to counter the persistent inflation and the uncertainties arising from the planned hospital reform throughout Germany.
The Asklepios healthcare facilities cared for a total of 854,558 inpatients and outpatients in the first quarter of 2023 (3M 2022: 836,025). At EUR 1,341.8 million, revenue was up on the previous year's figure (3M 2022: EUR 1,276.3 million).
In the first quarter, the cost of materials rose to EUR
345.8
million (3M 2022: EUR
321.5
million). The cost of materials ratio came to 25.8% in the first quarter of 2023 (3M 2022: 25.2%). The staff costs ratio was also higher than in the previous year at 68.9% (3M 2022: 68.0%). Absolute staff costs increased by EUR
57.2 million to EUR
924.9 million (3M 2022: EUR
867.7 million). The other expenses ratio came to 8.1% (3M 2022: 7.7%).
Overall, consolidated net income (EAT) for January to March 2023 amounted to EUR
9.2 million (3M 2022: EUR
6.4 million). The EAT margin was 0.7% (3M 2022: 0.5%).
Despite the difficult environment, Asklepios made high investments in its approximately 170 healthcare facilities. Investments including subsidies amounted to EUR
77.4 million. Internally financed capital expenditure increased by EUR
11.3 million to EUR
47.4
million in the first quarter of 2023 (3M 2022: EUR
36.1 million).
The Asklepios Group had a sound financial position in the first quarter of 2023: The ratio of net debt to EBITDA for the past 12 months was 3.4x (31 December 2022: 3.5x). Cash and cash equivalents amounted to EUR
661.1 million as at 31 March 2023 (31 December 2022: EUR
634.6 million).
In the 2023 financial year, the Asklepios Group anticipates a stable revenue performance, largely positive economic development and a slight, sustainable increase in EAT. Asklepios will react flexibly to external economic challenges and effectively handle changes in medical or regulatory requirements.
About Asklepios
Asklepios Kliniken is one of the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly qualified care for its patients, with a clear commitment to medical quality, innovation and social responsibility. On this basis, Asklepios has been developing dynamically since it was founded around 40 years ago. The Group currently has around 170 healthcare facilities throughout Germany. These include acute care hospitals of all different care levels, university hospitals, specialist clinics, psychiatric facilities, forensic institutions, rehabilitation clinics, nursing homes and medical centres. In the 2022 financial year, around 3.6 million patients were treated at the Asklepios Group's facilities. The company has more than 67,000 employees.
IR contact
Mirjam Constantin
Head of Group ESG & Sustainability/ Manager Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 - 61462 Königstein-Falkenstein
Tel.: +49 61 74 90-1166
Fax: +49 61 74 90-1110
PR contact
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226 - 22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639
Visit Asklepios online, on Facebook or on YouTube:
gesundleben.asklepios.com
25.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at